mRNA |
MS-275 |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.007 |
mRNA |
BRD-K04800985 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.007 |
mRNA |
CP724714 |
GDSC1000 |
pan-cancer |
AAC |
-0.093 |
0.007 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.007 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.007 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.007 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.008 |
mRNA |
EKB-569 |
GDSC1000 |
pan-cancer |
AAC |
-0.088 |
0.009 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.01 |
mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
0.086 |
0.01 |